IBM, Refinitiv Partner on Machine Learning Project to Better Understand Market Correlations

The two companies are in the early stages of using causal inference to help firms build machine learning models that are better able to handle disruption from events like the Covid-19 pandemic.

The market effects of the Covid-19 outbreak have thrown off machine learning models that historically relied on correlations between different types of datasets—correlations that are no longer making sense. “We are living through an era now where all of the correlations [in machine learning models] sort of broke overnight,” says David Cox, IBM director of the MIT–IBM Watson AI Lab. 

For example, before the onset of the pandemic, customers who shopped at an upscale grocery store might also have

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Waters Wrap: The tough climb for startups

Anthony speaks with two seasoned technologists to better understand why startups have such a tough time getting banks and asset managers to sign on the dotted line.

FCA declines to directly regulate market data prices

A year-long investigation by the UK regulator to determine whether competition is hindered in the wholesale data markets has concluded with its decision not to directly regulate much-maligned data pricing and licensing structures.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here